Atlas Trials

Combination Radiation and PD-1 Inhibition in Metastatic or Recurrent Renal Cell Carcinoma (RCC)

Clinical trial NCT02962804 · WITHDRAWN

Trial details

NCT number
NCT02962804
Sponsor
University of Kansas Medical Center
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Renal Cell
Primary completion
2017-02-02
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.